Loading stock data…
AEMD
$2.30+0.07 (+3.14%)
Market ClosedLast close May 1
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Aethlon Medical, Inc. in the Healthcare sector is trading at $2.30. The stock is currently near its 52-week low of $1.36, remaining 57.7% below its 200-day moving average. Technical signals show neutral RSI of 58 and bearish MACD signal, explaining why AEMD maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 58) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$2.30
Potential Upside
5%
Whystock Fair Value$2.42
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for ap...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$3.59M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.52
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-171.64%
Volume
Today's trading volume
8,129
Recent News
Aethlon Medical Inc (AEMD) Q3 2026 Earnings Call Highlights: Progress in Oncology Trials and ...
Aethlon Medical Inc (AEMD) reports significant strides in oncology trials and research platform expansion, despite facing increased operating expenses.
Aethlon Medical, Inc. Q3 2026 Earnings Call Summary
Moby summary of Aethlon Medical, Inc.'s Q3 2026 earnings call
Aethlon Medical announces pricing of $4.5M common stock, warrant offering
Aethlon Medical (AEMD) announced the pricing of a public offering of an aggregate of 5M shares of its common stock and warrants to purchase up to 5M shares of common stock at a combined public offering price of 90c per share and accompanying warrant. The warrants will have an exercise price of 90c per share, will be exercisable immediately upon issuance and will expire on the fifth anniversary of the original issuance date. The closing of the offering is expected to occur on or about September 5
BC-Most Active Stocks
Raytech Holding Ltd. 19,129,535 2.735
Aethlon Medical Inc (AEMD) Q1 2026 Earnings Call Highlights: Strategic Focus on Australian ...
Aethlon Medical Inc (AEMD) reports progress in its Australian trial, cost-saving measures, and plans for future funding amid strategic shifts.